Role of TGFβ signaling in the pathogenesis of Alzheimer’s disease

Frontiers in Cellular Neuroscience

Volumn 9, Issue OCTOBER, 2015, Pages

  von Bernhardi, Rommy ^a   Cornejo, Francisca ^a   Parada, Guillermo E ^a   Eugenín, Jaime ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD DE SANTIAGO DE CHILE   (Chile)

Author keywords

Aging; Cytokines; Glia; MAPK; Neurodegenerative diseases; Neuroinflammation; NF B; Transforming growth factor

Indexed keywords

ALPHA3 INTEGRIN; AMYLOID BETA PROTEIN; BETA1 INTEGRIN; CD14 ANTIGEN; CD51 ANTIGEN; CHEMOKINE RECEPTOR CCR5; DOUBLECORTIN; ENDOTOXIN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; N METHYL DEXTRO ASPARTIC ACID; PROTEASOME; SCAVENGER RECEPTOR; SMAD3 PROTEIN; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

AGING; ALZHEIMER DISEASE; ARTICLE; AUTOPHAGY; CELL ACTIVATION; CELL AGING; CELL DAMAGE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; COGNITIVE DEFECT; CYTOTOXICITY; DEGENERATIVE DISEASE; EXCITOTOXICITY; GENE; GENE EXPRESSION; HUMAN; HYPOXIA; INNATE IMMUNITY; ISCHEMIA; MICROGLIA; MSR1 GENE; NERVOUS SYSTEM INFLAMMATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHAGOCYTOSIS; PROTEIN DEGRADATION; RISK FACTOR; WNT SIGNALING PATHWAY;

EID: 84947577635     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00426     Document Type: Article

References (254)

1. Aad, G., Abbott, B., Abdallah, J., Abdelalim, A. A., Abdesselam, A., Abdinov, O., et al. (2011). Measurement of the W+ W-cross section in sqrt(s) = 7 TeV pp collisions with ATLAS. Phys. Rev. Lett. 107:041802. doi: 10.2172/982232
2. Abutbul, S., Shapiro, J., Szaingurten-Solodkin, I., Levy, N., Carmy, Y., Baron, R., et al. (2012). TGF-beta signaling through SMAD2/3 induces the quiescent microglialpheno type within the CNS environment. Glia 60, 1160-1171. doi: 10.1002/glia.22343
3. Adler, A. S., Kawahara, T. L., Segal, E., and Chang, H. Y. (2008). Reversal of aging by NF kappa B blockade. Cell Cycle 7, 556-559. doi: 10.4161/cc.7.5.5490
4. Adler, A. S., Sinha, S., Kawahara, T. L., Zhang, J. Y., Segal, E., and Chang, H. Y. (2007). Motif module map reveals enforcement of aging by continual NF-kappaB activity. GenesDev. 21,3244-3257. doi: 10.1101/gad.1588507
5. Akama, K. T., Albanese, C., Pestell, R. G., and Van Eldik, L. J. (1998). Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism. Proc. Natl. Acad. Sci. USA 95, 5795-5800. doi: 10.1073/pnas.95.10.5795
6. Akama, K. T., and Van Eldik, L. J. (2000). Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta-and tumor necrosis factor-alpha (TNFalpha)-dependent and involves a TNFalpha receptor-associated factor-and NFkappaB-inducing kinase-dependent signaling mechanism. J. Biol. Chem. 275, 7918-7924. doi: 10.1074/jbc.275.11.7918
7. Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G. M., et al. (2000). Inflammation and Alzheimer’s disease. Neurobiol. Aging 21, 383-421. doi: 10.1016/S0197-4580(00)00124-X
8. Alarcon, R., Fuenzalida, C., Santibanez, M., and von Bernhardi, R. (2005). Expression of scavenger receptors in glial cells. Comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound beta-amyloid. J. Biol. Chem. 280, 30406-30415. doi: 10.1074/jbc.m414686200
9. Aldskogius, H., Liu, L., and Svensson, M. (1999). Glial responses to synaptic damage and plasticity. J. Neurosci. Res. 58, 33-41. doi: 10.1002/(sici)1097-4547(19991001)58:1 <33::aid-jnr5>3.0.co;2-m
10. Amara, F. M., Junaid, A., Clough, R. R., and Liang, B. (1999). TGF-beta(1), regulation of alzheimer amyloid precursor protein mRNA expression in a normal human astrocyte cell line: mRNA stabilization. Brain Res. Mol. Brain Res. 71, 42-49. doi: 10.1016/s0169-328x(99)00158-8
11. Argmann, C. A., Van Den Diepstraten, C. H., Sawyez, C. G., Edwards, J. Y., Hegele, R. A., Wolfe, B. M., et al. (2001). Transforming growth factor-beta1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants. Arterioscler. Thromb. Vasc. Biol. 21, 2011-2018. doi: 10.1161/hq1201.099426
12. Baccante, G., Mincione, G., Di Marcantonio, M. C., Piccirelli, A., Cuccurullo, F., and Porreca, E. (2004). Pravastatin up-regulates transforming growth factor-beta1 in THP-1 human macrophages: effect on scavenger receptor class A expression. Biochem. Biophys. Res. Commun. 314, 704-710.doi: 10.1016/j.bbrc.2003.12.150
13. Baig, S., van Helmond, Z., and Love, S. (2009). Tau hyperphosphorylation affects Smad 2/3 translocation. Neuroscience 163, 561-570. doi: 10.1016/j.neuroscience.2009.06.045
14. Benveniste, E. N., Nguyen, V. T., and O’Keefe, G. M. (2001). Immunological aspects of microglia: relevance to Alzheimer’s disease. Neurochem. Int. 39, 381-391. doi: 10.1016/s0197-0186(01)00045-6
15. Beynon, A. L., Thome, J., and Coogan, A. N. (2009). Age and time of day influences on the expression of transforming growth factor-beta and phosphorylated SMAD3 in the mouse suprachiasmatic and paraventricular nuclei. Neuroimmunomodulation 16, 392-399. doi: 10.1159/000228914
16. Bhat, N. R., Zhang, P., Lee, J. C., and Hogan, E. L. (1998). Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J. Neurosci. 18, 1633-1641.
17. Bjorkqvist, M., Wild, E. J., and Tabrizi, S. J. (2009). Harnessing immune alterations in neurodegenerative diseases. Neuron 64, 21-24. doi: 10.1016/j.neuron.2009. 09.034
18. Blanchette, J., Jaramillo, M., and Olivier, M. (2003). Signalling events involved in interferon-gamma-inducible macrophage nitric oxide generation. Immunology 108, 513-522. doi: 10.1046/j.1365-2567.2003.01620.x
19. Blobe, G. C., Schiemann, W. P., and Lodish, H. F. (2000). Role of transforming growth factor beta in human disease. N. Engl. J. Med. 342, 1350-1358. doi: 10.1056/NEJM200005043421807
20. Block, M. L., and Hong, J. S. (2005). Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog. Neurobiol. 76, 77-98. doi: 10.1016/j.pneurobio.2005.06.004
21. Block, M. L., Zecca, L., and Hong, J. S. (2007). Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8, 57-69. doi: 10.1038/nrn2038
22. Bornemann, K. D., Wiederhold, K. H., Pauli, C., Ermini, F., Stalder, M., Schnell, L., et al. (2001). Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice. Am. J. Pathol. 158, 63-73. doi: 10.1016/s0002-9440(10)63945-4
23. Bosco, P., Ferri, R., Salluzzo, M. G., Castellano, S., Signorelli, M., Nicoletti F, et al. (2013). Role of the transforming-growth-factor-beta1 gene in late-onset Alzheimer’s disease: implications for the treatment. Curr. Genomics 14, 147-156. doi: 10.2174/1389202911314020007
24. Bottalico, L. A., Wager, R. E., Agellon, L. B., Assoian, R. K., and Tabas, I. (1991). Transforming growth factor-beta 1 inhibits scavenger receptor activity in THP-1 human macrophages. J. Biol. Chem. 266, 22866-22871.
25. Boutros, T., Chevet, E., and Metrakos, P. (2008). Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death and cancer. Pharmacol. Rev. 60, 261-310.doi: 10.1124/pr.107.00106
26. Burton, T., Liang, B., Dibrov, A., and Amara, F. (2002). Transforming growth factor-beta-induced transcription of the Alzheimer beta-amyloid precursor protein gene involves interaction between the CTCF-complex and Smads. Biochem. Biophys. Res. Commun. 295, 713-723. doi: 10.1016/s0006-291x(02)00725-8
27. Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G. et al. (2014). Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat. Neurosci. 17, 131-143. doi: 10.1038/nn.3599
28. Buxton, I. L., and Duan, D. (2008). Cyclic GMP/protein kinase G phosphorylation of Smad3 blocks transforming growth factor-beta-induced nuclear Smad translocation: a key antifibrogenic mechanism of atrial natriuretic peptide. Circ. Res. 102, 151-153. doi: 10.1161/CIRCRESAHA.107.170217
29. Bye, N., Zieba, M., Wreford, N. G., and Nichols, N. R. (2001). Resistance of the dentate gyrus to induced apoptosis during ageingis associated with increases in transforming growth factor-beta1 messenger RNA. Neuroscience 105, 853-862. doi: 10.1016/s0306-4522(01)00236-6
30. Calabrese, V., Guagliano, E., Sapienza, M., Panebianco, M., Calafato, S., Puleo E, et al. (2007). Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes. Neurochem. Res. 32, 757-773. doi: 10.1007/s11064-006-9203-y
31. Caraci, F., Battaglia, G., Bruno, V., Bosco, P., Carbonaro, V., Giuffrida, M. L., et al. (2011). TGF-beta1 Pathway as a new target for neuroprotection in Alzheimer’s disease. CNS Neurosci. Ther. 17, 237-249. doi: 10.1111/j.1755-5949.2009.00115.x
32. Caraci, F., Battaglia, G., Busceti, C., Biagioni, F., Mastroiacovo, F., Bosco, P., et al. (2008). TGF-beta 1 protects against Abeta-neurotoxicity via the phosphatidylinositol-3-kinase pathway. Neurobiol. Dis. 30, 234-242. doi: 10.1016/j.nbd.2008.01.007
33. Chen, S., Luo, D., Streit, W. J., and Harrison, J. K. (2002). TGF-beta1 upregulates CX3CR1 expression and inhibits fractalkine-stimulated signaling in rat microglia. J. Neuroimmunol. 133, 46-55. doi: 10.1016/s0165-5728(02)00354-5
34. Cholewa, J., Nikolic, D., and Post, S. R. (2010). Regulation of class A scavenger receptor-mediated cell adhesion and surface localization by PI3K: identification of a regulatorycytoplasmic motif. J. Leukoc. Biol. 87, 443-449. doi: 10.1189/jlb.0509318
35. Christie, R. H., Freeman, M., and Hyman, B. T. (1996). Expression of the macrophage scavenger receptor, a multifunctional lipoprotein receptor, in microglia associated with senile plaques in Alzheimer’s disease. Am. J. Pathol. 148, 399-403.
36. Chu, C. T., Levinthal, D. J., Kulich, S. M., Chalovich, E. M., and DeFranco, D. B. (2004). Oxidative neuronal injury. The dark side of ERK1/2. Eur. J. Biochem. 271, 2060-2066. doi: 10.1111/j.1432-1033.2004.04132.x
37. Chung, H., Brazil, M. I., Irizarry, M. C., Hyman, B. T., and Maxfield, F. R. (2001). Uptake of fibrillar beta-amyloid by microglia isolated from MSR-A (type I and type II) knockout mice. Neuroreport 12, 1151-1154. doi: 10.1097/00001756200105080-00020
38. Churcher, I. (2006). Tau therapeutic strategies for the treatment of Alzheimer’s disease. Curr. Top. Med. Chem. 6, 579-595. doi: 10.2174/156802606776743057
39. Colangelo, V., Schurr, J., Ball, M. J., Pelaez, R. P., Bazan, N. G., and Lukiw, W. J. (2002). Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J. Neurosci. Res. 70, 462-473. doi: 10.1002/jnr.10351
40. Combrinck, M. I., Perry, V. H., and Cunningham, C. (2002). Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease. Neuroscience 112,7-11. doi: 10.1016/s0306-4522(02)00030-1
41. Cornejo, F., and Von Bernhardi, R. (2013). Role of scavenger receptors in glia-mediated neuroinflammatory response associated with Alzheimer’s disease. Mediators Inflamm. 2013:895651. doi: 10.1155/2013/895651
42. Cornejo, F. A., Vruwink, M., Metz, C., Ramirez, G., and Von Bernhardi, R. (2014). Role of Scavenger Receptor Class A in glial cell activation in Alzheimer’s disease. Social Neuroscience Abstract 44th Annual Meeting, Washington, DC.
43. Cunningham, C., Wilcockson, D. C., Campion, S., Lunnon, K., and Perry, V. H. (2005). Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. 25, 9275-9284. doi: 10.1523/jneurosci.2614-05.2005
44. Dang, P. M., Morel, F., Gougerot-Pocidalo, M. A., and El Benna, J. (2003). Phosphorylation of the NADPH oxidase component p67(PHOX) by ERK2 and P38MAPK: selectivity of phosphorylated sites and existence of an intramolecular regulatory domain in the tetratricopeptide-rich region. Biochemistry 42,4520-4526. doi: 10.1021/bi0205754
45. Davis, J. N., III, and Chisholm, J. C. (1999). Alois alzheimer and the amyloid debate. Nature 400:810.doi: 10.1192/pb.24.12.480-a
46. Daynac, M., Pineda, J. R., Chicheportiche, A., Gauthier, L. R., Morizur, L., Boussin, F. D., et al. (2014). TGFbeta lengthens the G1 phase of stem cells in aged mouse brain. Stem Cells 32, 3257-3265. doi: 10.1002/stem.1815
47. de Magalhães, J. P., Curado, J., and Church, G. M. (2009). Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics 25, 875-881. doi: 10.1093/bioinformatics/btp073
48. de Sampaio e Spohr, T. C., Martinez, R., da Silva, E. F., Neto, V. M., and Gomes, C. (2002). Neuro-glia interaction effects on GFAP gene: a novel role for transforming growth factor-beta1. Eur. J. Neurosci. 16, 2059-2069. doi: 10.1046/j.1460-9568.2002.02283.x
49. Dean, J. L., Sully, G., Clark, A. R., and Saklatvala, J. (2004). The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation. Cell Signal. 16, 1113-1121. doi: 10.1016/j.cellsig.2004.04.006
50. Dell’Albani, P., Santangelo, R., Torrisi, L., Nicoletti, V. G., de Vellis, J., and Giuffrida Stella, A. M. (2001). JAK/STAT signalingpathwaymediates cytokine-induced iNOS expression in primaryastroglialcell cultures. J. Neurosci. Res. 65, 417-424. doi: 10.1002/jnr.1169
51. Derynck, R., and Zhang, Y. E. (2003). Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425, 577-584. doi: 10.1038/nature02006
52. DeWitt, D. A., Perry, G., Cohen, M., Doller, C., and Silver, J. (1998). Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer’s disease. Exp. Neurol. 149, 329-340. doi: 10.1006/exnr.1997.6738
53. Dhandapani, K. M., and Brann, D. W. (2003). Transforming growth factor-beta: a neuroprotective factor in cerebral ischemia. Cell Biochem. Biophys. 39, 13-22. doi: 10.1385/cbb:39:1:13
54. Di Filippo, M., Sarchielli, P., Picconi, B., and Calabresi, P. (2008). Neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders. Trends Pharmacol. Sci. 29, 402-412. doi: 10.1016/j.tips.2008.06.005
55. Dias, J. M., Alekseenko, Z., Applequist, J. M., and Ericson, J. (2014). Tgfbeta signaling regulates temporal neurogenesis and potency of neural stem cells in the CNS. Neuron 84, 927-939. doi: 10.1016/j.neuron.2014.10.033
56. Dixon, J. R., Selvaraj, S., Yue, F., Kim, A., Li, Y., Shen, Y., et al. (2012). Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 485, 376-380. doi: 10.1038/nature 11082
57. Docagne, F., Nicole, O., Gabriel, C., Fernandez-Monreal, M., Lesne, S., Ali, C., et al. (2002). Smad3-dependent induction of plasminogen activator inhibitor-1 in astrocytes mediates neuroprotective activity of transforming growth factor-beta 1 against NMDA-induced necrosis. Mol. Cell. Neurosci. 21, 634-644. doi: 10.1006/mcne.2002.1206
58. Doyle, K. P., Cekanaviciute, E., Mamer, L. E., and Buckwalter, M. S. (2010). TGFbeta signaling in the brain increases with aging and signals to astrocytes and innate immune cells in the weeks after stroke. J. Neuroinflammation 7:62. doi: 10.1186/1742-2094-7-62
59. Draude, G., and Lorenz, R. L. (2000). TGF-beta1 downregulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages. Am. J. Physiol. Heart Circ. Physiol. 278, H1042-H1048.
60. El Khoury, J., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., and Loike, J. D. (1996). Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 382, 716-719. doi: 10.1038/382716a0
61. Eljaschewitsch, E., Witting, A., Mawrin, C., Lee, T., Schmidt, P. M., Wolf, S., et al. (2006). The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 49, 67-79. doi: 10.1016/j.neuron.2005.11.027
62. Eyupoglu, I. Y., Bechmann, I., and Nitsch, R. (2003). Modification of microglia function protects from lesion-induced neuronal alterations and promotes sprouting in the hippocampus. FASEB J. 17, 1110-1111. doi: 10.1096/fj.02-0825fje
63. Feijoo, C., Campbell, D. G., Jakes, R., Goedert, M., and Cuenda, A. (2005). Evidence that phosphorylation of the microtubule-associated protein Tau by SAPK4/p38delta at Thr50 promotes microtubule assembly. J. Cell Sci. 118, 397-408. doi: 10.1242/jcs.01655
64. Floden, A. M., and Combs, C. K. (2011). Microglia demonstrate age-dependent interaction with amyloid-beta fibrils. J. Alzheimers. Dis. 25, 279-293. doi: 10.3233/JAD-2011-101014
65. Flores, B., and von Bernhardi, R. (2012). Transforming growth factor beta1 modulates amyloid beta-induced glial activation through the Smad3-dependent induction of MAPK phosphatase-1. J. Alzheimers Dis. 32, 417-429. doi: 10.3233/JAD-2012-120721
66. Franceschi, C., Bonafe, M., Valensin, S., Olivieri, F., De Luca, M., Ottaviani, E., et al. (2000). Inflamm-aging. An evolutionary perspective on immunosene scence. Ann. N Y Acad. Sci. 908, 244-254. doi: 10.1111/j.1749-6632.2000.tb06651.x
67. Frenkel, D., Wilkinson, K., Zhao, L., Hickman, S. E., Means, T. K., Puckett, L., et al. (2013). Scara1 deficiency impairs clearance of soluble amyloid-beta by mononuclear phagocytes and accelerates Alzheimer’s-like disease progression. Nat. Commun. 4:2030. doi: 10.1038/ncomms3030
68. Gabuzda, D., Busciglio, J., Chen, L. B., Matsudaira, P., and Yankner, B. A. (1994). Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J. Biol. Chem. 269, 13623-13628.
69. Gao, H. M., and Hong, J. S. (2008). Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol. 29, 357-365. doi: 10.1016/j.it.2008.05.002
70. George, O., Parducz, A., Dupret, D., Kharouby, M., Le Moal, M., Piazza, P. V., et al. (2006). Smad-dependent alterations of PPT cholinergic neurons as a pathophysiological mechanism of age-related sleep-dependent memory impairments. Neurobiol. Aging 27, 1848-1858. doi: 10.1016/j.neurobiolaging.2005.10.014
71. Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., and Gage, F. H. (2010). Mechanisms underlying inflammation in neurodegeneration. Cell 140, 934. doi: 10.1016/j.cell.2010.02.016
72. Godbout, J. P., Chen, J., Abraham, J., Richwine, A. F., Berg, B. M., Kelley, K. W., et al. (2005). Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J. 19, 1329-1331. doi: 10.1096/fj.05-3776fje
73. Godoy, B., Murgas, P., Tichauer, J., and Von Bernhardi, R. (2012). Scavenger receptor class A ligands induce secretion of IL1beta and exert a modulatory effect on the inflammatory activation of astrocytes in culture. J. Neuroimmunol. 251, 6-13. doi: 10.1016/j.jneuroim.2012.06.004
74. Gordon, S. (2003). Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35. doi: 10.1038/nri978
75. Gough, D. J., Levy, D. E., Johnstone, R. W., and Clarke, C. J. (2008). IFNgamma signaling-does it mean JAK-STAT? Cytokine Growth Factor Rev. 19, 383-394. doi: 10.1016/j.cytogfr.2008.08.004
76. Handattu, S. P., Garber, D. W., Monroe, C. E., Van Groen, T., Kadish, I., Nayyar, G., et al. (2009). Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model ofAlzheimer’s disease. Neurobiol. Dis. 34, 525-534. doi: 10.1016/j.nbd.2009.03.007
77. Handattu, S. P., Monroe, C. E., Nayyar, G., Palgunachari, M. N., Kadish, I., Van Groen, T., et al. (2013). In vivo and in vitro effects of an apolipoprotein e mimetic peptide on amyloid-beta pathology. J. Alzheimers Dis. 36, 335-347. doi: 10.3233/JAD-122377
78. Hanisch, U. K., and Kettenmann, H. (2007). Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387-1394. doi: 10.1038/nn1997
79. Hardy, J., and Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297, 353-356. doi: 10.1126/science.1072994
80. Hayashi, Y., Yoshida, M., Yamato, M., Ide, T., Wu, Z., Ochi-Shindou, M., et al. (2008). Reverse of age-dependent memory impairment and mitochondrial DNA damage in microglia by an overexpression of human mitochondrial transcription factor a in mice. J. Neurosci. 28, 8624-8634. doi: 10.1523/jneurosci.1957-08.2008
81. He, P., Zhong, Z., Lindholm, K., Berning, L., Lee, W., Lemere, C., et al. (2007). Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer’s mice. J. CellBiol. 178, 829-841. doi: 10.1084/jem2048oia23
82. Heldin, C. H., and Moustakas, A. (2012). Role of Smads in TGFbeta signaling. Cell Tissue Res. 347, 21-36. doi: 10.1007/s00441-011-1190-x
83. Helenius, M., Hanninen, M., Lehtinen, S. K., and Salminen, A. (1996). Changes associated with aging and replicative senescence in the regulation of transcription factor nuclear factor-kappa B. Biochem. J. 318, 603-608. doi: 10.1042/bj3180603
84. Hemmer, B., Archelos, J. J., and Hartung, H. P. (2002). New concepts in the immunopathogenesis of multiple sclerosis. Nat. Rev. Neurosci. 3, 291-301. doi: 10.1038/nrn784
85. Heneka, M. T., and O’banion, M. K. (2007). Inflammatory processes in Alzheimer’s disease. J. Neuroimmunol. 184, 69-91. doi: 10.1016/j.jneuroim.2006.11.017
86. Heneka, M. T., O’banion, M. K., Terwel, D., and Kummer, M. P. (2010). Neuroinflammatory processes in Alzheimer’s disease. J. Neural Transm. 117, 947. doi: 10.1007/s00702-010-0438-z
87. Herrera-Molina, R., and Von Bernhardi, R. (2005). Transforming growth factor-beta 1 produced by hippocampal cells modulates microglial reactivity in culture. Neurobiol. Dis. 19, 229-236. doi: 10.1016/j.nbd.2005.01.003
88. Herrera-Molina, R., Flores, B., Orellana, J. A., and Von Bernhardi, R. (2012). Modulation ofinterferon-gamma-induced glial cell activation bytransforming growth factor beta1: a role for STAT1 and MAPK pathways. J. Neurochem. 123, 113-123. doi: 10.1111/j.1471-4159.2012.07887.x
89. Herrup, K. (2010). Reimagining Alzheimer’s disease-an age-based hypothesis. J. Neurosci. 30, 16755-16762. doi: 10.1523/jneurosci.4521-10.2010
90. Hickman, S. E., Allison, E. K., and El Khoury, J. (2008). Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer’s disease mice. J. Neurosci. 28, 8354-8360. doi: 10.1523/jneurosci.0616-08.2008
91. Hinks, G. L., and Franklin, R. J. (2000). Delayed changes in growth factor gene expression during slow remyelination in the CNS of aged rats. Mol. Cell. Neurosci. 16, 542-556. doi: 10.1006/mcne.2000.0897
92. Hirsch, E. C., and Hunot, S. (2009). Neuroinflammation in Parkinson’s disease: a target for neuroprotection? Lancet Neurol. 8, 382-397. doi: 10.1016/s1474-4422(09)70062-6
93. Holwerda, S. J., and De Laat, W. (2013). CTCF: the protein, the binding partners, the binding sites and their chromatin loops. Philos. Trans. R. Soc. Lond. B Biol. Sci. 368:20120369. doi: 10.1098/rstb.2012.0369
94. Honda, M., Akiyama, H., Yamada, Y., Kondo, H., Kawabe, Y., Takeya, M., et al. (1998). Immunohistochemical evidence for a macrophage scavenger receptor in Mato cells and reactive microglia of ischemia and Alzheimer’s disease. Biochem. Biophys. Res. Commun. 245, 734-740. doi: 10.1006/bbrc.1998.8120
95. Hu, S., Sheng, W. S., Peterson, P. K., and Chao, C. C. (1995). Cytokine modulation of murine microglial cell superoxide production. Glia 13, 45-50. doi: 10.1002/glia.440130106
96. Imoto, S., Sugiyama, K., Muromoto, R., Sato, N., Yamamoto, T., and Matsuda, T. (2003). Regulation of transforming growth factor-beta signaling by protein inhibitor of activated STAT, PIASy through Smad3. J. Biol. Chem. 278, 34253-34258. doi: 10.1074/jbc.m304961200
97. Ishida, Y., Kondo, T., Takayasu, T., Iwakura, Y., and Mukaida, N. (2004). The essential involvement of cross-talk between IFN-gamma and TGF-beta in the skin wound-healing process. J. Immunol. 172, 1848-1855. doi: 10.4049/jimmunol.172.3.1848
98. Jang, B. C., Lim, K. J., Suh, M. H., Park, J. G., and Suh, S. I. (2007). Dexamethasone suppresses interleukin-1beta-induced human beta-defensin 2 mRNA expression: involvement of p38 MAPK, JNK, MKP-1 and NF-kappaB transcriptional factor in A549 cells. FEMS Immunol. Med. Microbiol. 51, 171-184. doi: 10.1111/j.1574-695x.2007.00293.x
99. Jellinger, K. A. (2006). Alzheimer 100-highlights in the history of Alzheimer research. J. Neural Transm. 113, 1603-1623. doi: 10.1007/s00702-006-0578-3
100. Johns, L. D., Babcock, G., Green, D., Freedman, M., Sriram, S., and Ransohoff, R. M. (1992). Transforming growth factor-beta 1 differentially regulates proliferation and MHC class-II antigen expression in forebrain and brainstem astrocyte primary cultures. Brain Res. 585, 229-236. doi: 10.1016/0006-8993(92)91211-v
101. Jono, H., Xu, H., Kai, H., Lim, D. J., Kim, Y. S., Feng, X. H., et al. (2003). Transforming growth factor-beta-Smad signaling pathway negatively regulates nontypeable Haemophilus influenzae-induced MUC5AC mucin transcription via mitogen-activated protein kinase (MAPK) phosphatase-1-dependent inhibition of p38 MAPK. J. Biol. Chem. 278, 27811-27819. doi: 10.1074/jbc.m301773200
102. Juraskova, B., Andrys, C., Holmerova, I., Solichova, D., Hrnciarikova, D., Vankova, H., et al. (2010). Transforming growth factor beta and soluble endoglin in the healthy senior and in Alzheimer’s disease patients. J. Nutr. Health Aging14, 758-761. doi: 10.1007/s12603-010-0325-1
103. Kandasamy, M., Lehner, B., Kraus, S., Sander, P. R., Marschallinger, J., Rivera, F. J., et al. (2014). TGF-beta signalling in the adult neurogenic niche promotes stem cell quiescence as well as generation of new neurons. J. Cell. Mol. Med. 18, 1444-1459. doi: 10.1111/jcmm.12298
104. Kassel, O., Sancono, A., Kratzschmar, J., Kreft, B., Stassen, M., and Cato, A. C. (2001). Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J. 20, 7108-7116. doi: 10.1093/emboj/20.24.7108
105. Katayama, T., Sakaguchi, E., Komatsu, Y., Oguma, T., Uehara, T., and Minami, M. (2010). Sustained activation of ERK signaling in astrocytes is critical for neuronal injury-induced monocyte chemoattractant protein-1 production in rat corticostriatal slice cultures. Eur. J. Neurosci. 31, 1359-1367. doi: 10.1111/j.1460-9568.2010.07160.x
106. Katsel, P. L., Davis, K. L., and Haroutunian, V. (2005). Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer’s disease. Int. Rev. Neurobiol. 63, 41-82. doi: 10.1016/s0074-7742(05)63003-6
107. Kettenmann, H., Hanisch, U. K., Noda, M., and Verkhratsky, A. (2011). Physiology ofmicroglia. Physiol. Rev. 91,461-553. doi: 10.1152/physrev.00011.2010
108. Kim, S. U., and de Vellis, J. (2005). Microglia in health and disease. J. Neurosci. Res. 81, 302-313. doi: 10.1002/jnr.20562
109. Kim, S. W., Yoon, S. J., Chuong, E., Oyolu, C., Wills, A. E., Gupta, R., et al. (2011). Chromatin and transcriptional signatures for Nodal signaling during endoderm formation in hESCs. Dev. Biol. 357, 492-504. doi: 10.1016/j.ydbio.2011.06.009
110. King, E. M., Holden, N. S., Gong, W., Rider, C. F., and Newton, R. (2009). Inhibition of NF-kappaB-dependent transcription by MKP-1: transcriptional repression by glucocorticoids occurring via p 38 MAPK. J. Biol. Chem. 284, 26803-26815. doi: 10.1074/jbc.M109.028381
111. Klegeris, A., Bissonnette, C. J., and McGeer, P. L. (2005). Modulation of human microglia and THP-1 cell toxicity by cytokines endogenous to the nervous system. Neurobiol. Aging 26, 673-682. doi: 10.1016/j.neurobiolaging.2004.06.012
112. Kraus, S., Lehner, B., Reichhart, N., Couillard-Despres, S., Wagner, K., Bogdahn, U., et al. (2013). Transforming growth factor-beta1 primes proliferating adult neural progenitor cells to electrophysiological functionality. Glia 61, 1767-1783. doi: 10.1002/glia.22551
113. Krausgruber, T., Blazek, K., Smallie, T., Alzabin, S., Lockstone, H., Sahgal, N., et al. (2011). IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat. Immunol 12, 231-238. doi: 10.1038/ni.1990
114. Kreutzberg, G. W. (1996). Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312-318. doi: 10.1016/0166-2236(96)10049-7
115. Larbi, A., Franceschi, C., Mazzatti, D., Solana, R., Wikby, A., and Pawelec, G. (2008). Aging of the immune system as a prognostic factor for human longevity. Physiology (Bethesda) 23, 64-74. doi: 10.1152/physiol.00040.2007
116. Le, Y., Iribarren, P., Gong, W., Cui, Y., Zhang, X., and Wang, J. M. (2004). TGF-beta1 disrupts endotoxin signaling in microglial cells through Smad3 and MAPK pathways. J. Immunol. 173, 962-968. doi: 10.4049/jimmunol.173.2.962
117. Lee, C. K., Weindruch, R., and Prolla, T. A. (2000). Gene-expression profile of the ageing brain in mice. Nat. Genet. 25, 294-297. doi: 10.1038/77046
118. Lee, H. G., Ueda, M., Zhu, X., Perry, G., and Smith, M. A. (2006). Ectopic expression of phospho-Smad2 in Alzheimer’s disease: uncoupling of the transforming growth factor-beta pathway? J. Neurosci. Res. 84, 1856-1861. doi: 10.1002/jnr.21072
119. Lee, J. H., Woo, J. H., Woo, S. U., Kim, K. S., Park, S. M., Joe, E. H., et al. (2008). The 15-deoxy-delta 12,14-prostaglandin J2 suppresses monocyte chemoattractant protein-1 expression in IFN-gamma-stimulated astrocytes through induction ofMAPK phosphatase-1. J. Immunol. 181, 8642-8649. doi: 10.4049/jimmunol.181.12.8642
120. Lee, S. Y., Ha, T. Y., Son, D. J., Kim, S. R., and Hong, J. T. (2005a). Effect of sesaminol glucosides on beta-amyloid-induced PC12 cell death through antioxidant mechanisms. Neurosci. Res. 52, 330-341. doi: 10.1016/j.neures.2005.04.003
121. Lee, S. Y., Lee, J. W., Lee, H., Yoo, H. S., Yun, Y. P., Oh, K. W., et al. (2005b). Inhibitory effect of green tea extract on beta-amyloid-induced PC12 cell death by inhibition of the activation of NF-kappaB and ERK/p38 MAP kinase pathway through antioxidant mechanisms. Brain Res. Mol. Brain Res. 140, 45-54. doi: 10.1016/j.molbrainres.2005.07.009
122. Lesne, S., Docagne, F., Gabriel, C., Liot, G., Lahiri, D. K., Buee, L., et al. (2003). Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in transgenic mice. J. Biol. Chem. 278, 18408-18418. doi: 10.1074/jbc.m300819200
123. Letiembre, M., Hao, W., Liu, Y., Walter, S., Mihaljevic, I., Rivest, S., et al. (2007). Innate immune receptor expression in normal brain aging. Neuroscience 146, 248-254. doi: 10.1016/j.neuroscience.2007.01.004
124. Li, L., Lu, J., Tay, S. S., Moochhala, S. M., and He, B. P. (2007). The function of microglia, either neuroprotection or neurotoxicity, is determined by the equilibrium among factors released from activated microglia in vitro. Brain Res. 1159, 8-17. doi: 10.1016/j.brainres.2007.04.066
125. Li, R., Yang, L., Lindholm, K., Konishi, Y., Yue, X., Hampel, H., et al. (2004). Tumor necrosis factor death receptor signaling cascade is required for amyloid-beta protein-induced neuron death. J. Neurosci. 24, 1760-1771. doi: 10.1523/jneurosci.4580-03.2004
126. Lieb, K., Engels, S., and Fiebich, B. L. (2003). Inhibition of LPS-induced iNOS and NO synthesis in primary rat microglial cells. Neurochem. Int. 42, 131-137. doi: 10.1016/s0197-0186(02)00076-1
127. Lifshitz, V., Weiss, R., Levy, H., and Frenkel, D. (2013). Scavenger receptor A deficiency accelerates cerebrovascular amyloidosis in an animal model. J. Mol. Neurosci. 50, 198-203. doi: 10.1007/s12031-012-9909-z
128. Liu, B., Wang, K., Gao, H. M., Mandavilli, B., Wang, J. Y., and Hong, J. S. (2001). Molecular consequences of activated microglia in the brain: overactivation induces apoptosis. J. Neurochem. 77, 182-189. doi: 10.1046/j.1471-4159.2001.00216.x
129. Liu, F. (2006). Smad3 phosphorylation by cyclin-dependent kinases. Cytokine Growth Factor Rev. 17, 9-17. doi: 10.1016/j.cytogfr.2005.09.010
130. Liu, X., Wu, Z., Hayashi, Y., and Nakanishi, H. (2012). Age-dependent neuroinflammatory responses and deficits in long-term potentiation in the hippocampus during systemic inflammation. Neuroscience 216, 133-142. doi: 10.1016/j.neuroscience.2012.04.050
131. Liu, Y., Shepherd, E. G., and Nelin, L. D. (2007). MAPK phosphatases-regulating the immune response. Nat. Rev. Immunol. 7, 202-212. doi: 10.1038/nri2035
132. Lucas, M., Zhang, X., Prasanna, V., and Mosser, D. M. (2005). ERK activation following macrophage FcgammaR ligation leads to chromatin modifications at the IL-10 locus. J. Immunol. 175, 469-477. doi: 10.4049/jimmunol.175.1.469
133. Lue, L. F., Kuo, Y. M., Beach, T., and Walker, D. G. (2010). Microglia activation and anti-inflammatory regulation in Alzheimer’s disease. Mol. Neurobiol. 41, 115-128. doi: 10.1007/s12035-010-8106-8
134. Lukiw, W. J. (2004). Gene expression profiling in fetal, aged and Alzheimer hippocampus: a continuum of stress-related signaling. Neurochem. Res. 29, 1287-1297. doi: 10.1023/b:nere.0000023615.89699.63
135. Luterman, J. D., Haroutunian, V., Yemul, S., Ho, L., Purohit, D., Aisen, P. S., et al. (2000). Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia. Arch. Neurol. 57, 1153-1160. doi: 10.1001/archneur.57.8.1153
136. Lyons, A., Murphy, K. J., Clarke, R., and Lynch, M. A. (2011). Atorvastatin prevents age-related and amyloid-beta-induced microglial activation by blocking interferon-gamma release from natural killer cells in the brain. J. Neuroinflammation 8:27. doi: 10.1186/1742-2094-8-27
137. Ma, Y. P., Ma, M. M., Ge, S., Guo, R. B., Zhang, H. J., Frey, W. H., II, et al. (2007). Intranasally delivered TGF-beta1 enters brain and regulates gene expressions of its receptors in rats. Brain Res. Bull. 74, 271-277. doi: 10.1016/j.brainresbull.2007.06.021
138. Marcus, J. S., Karackattu, S. L., Fleegal, M. A., and Sumners, C. (2003). Cytokine-stimulated inducible nitric oxide synthase expression in astroglia: role of Erk mitogen-activated protein kinase and NF-kB. Glia 41, 152-160. doi: 10.1002/glia.10168
139. Martinez, F. O., Sica, A., Mantovani, A., and Locati, M. (2008). Macrophage activation and polarization. Front. Biosci. 13, 453-461. doi: 10.2741/2692
140. Mazur-Kolecka, B., Frackowiak, J., Le Vine, H., III, Haske, T., Evans, L., Sukontasup, T., et al. (2003). TGFbeta1 enhances formation of cellular Abeta/apoE deposits in vascular myocytes. Neurobiol. Aging 24, 355-364. doi: 10.1016/s0197-4580(02)00095-7
141. McCartney-Francis, N. L., and Wahl, S. M. (2002). Dysregulation of IFN-gamma signaling pathways in the absence of TGF-beta 1. J. Immunol. 169, 5941-5947. doi: 10.4049/jimmunol.169.10.5941
142. Medeiros, R., Prediger, R. D., Passos, G. F., Pandolfo, P., Duarte, F. S., Franco, J. L., et al. (2007). Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer’s disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein. J. Neurosci. 27, 5394-5404. doi: 10.1523/jneurosci.5047-06.2007
143. Michael, D. R., Salter, R. C., and Ramji, D. P. (2012). TGF-beta inhibits the uptake of modified low density lipoprotein by human macrophages through a Smad-dependent pathway: a dominant role for Smad-2. Biochim. Biophys. Acta 1822, 1608-1616. doi: 10.1016/j.bbadis.2012.06.002
144. Milner, R. (2009). Microglial expression of alphavbeta3 and alphavbeta5 integrins is regulated by cytokines and the extracellular matrix: beta5 integrin null microglia show no defects in adhesion or MMP-9 expression on vitronectin. Gila 57, 714-723. doi: 10.1002/glia.20799
145. Mittaud, P., Labourdette, G., Zingg, H., and Guenot-Di Scala, D. (2002). Neurons modulate oxytocin receptor expression in rat cultured astrocytes: involvement of TGF-beta and membrane components. Glia 37, 169-177. doi: 10.1002/glia.10029
146. Mocali, A., Cedrola, S., Della Malva, N., Bontempelli, M., Mitidieri, V. A., Bavazzano, A., et al. (2004). Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease. Exp. Gerontol. 39, 1555-1561. doi: 10.1016/j.exger.2004.07.007
147. Mosser, D. M. (2003). The many faces of macrophage activation. J. Leukoc. Biol. 73, 209-212. doi: 10.1189/jlb.0602325
148. Mosser, D. M., and Edwards, J. P. (2008). Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969. doi: 10.1038/nri2448
149. Mullen, A. C., Orlando, D. A., Newman, J. J., Loven, J., Kumar, R. M., Bilodeau, S., et al. (2011). Master transcription factors determine cell-type-specific responses to TGF-beta signaling. Cell 147, 565-576. doi: 10.1016/j.cell.2011.08.050
150. Munoz, L., and Ammit, A. J. (2010). Targeting p38 MAPK pathway for the treatment of Alzheimer’s disease. Neuropharmacology 58, 561-568. doi: 10.1016/j.neuropharm.2009.11.010
151. Munoz, L., Ralay Ranaivo, H., Roy, S. M., Hu, W., Craft, J. M., McNamara, L. K., et al. (2007). A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer’s disease mouse model. J. Neuroinflammation 4:21. doi: 10.1186/1742-2094-4-21
152. Murgas, P., Cornejo, F. A., Merino, G., and Von Bernhardi, R. (2014). SR-A regulates the inflammatory activation of astrocytes. Neurotox. Res. 25, 68-80. doi: 10.1007/s12640-013-9432-1
153. Murgas, P., Godoy, B., and Von Bernhardi, R. (2012). Abeta potentiates inflammatory activation of glial cells induced by scavenger receptor ligands and inflammatory mediators in culture. Neurotox. Res. 22, 69-78. doi: 10.1007/s12640-011-9306-3
154. Muriach, M., Flores-Bellver, M., Romero, F. J., and Barcia, J. M. (2014). Diabetes and the brain: oxidative stress, inflammation and autophagy. Oxid. Med. Cell. Longev. 2014:102158. doi: 10.1155/2014/102158
155. Nakajima, K., Tohyama, Y., Maeda, S., Kohsaka, S., and Kurihara, T. (2007). Neuronal regulation by which microglia enhance the production of neurotrophic factors for GABAergic, catecholaminergic and cholinergic neurons. Neurochem. Int. 50, 807-820. doi: 10.1016/j.neuint.2007.02.006
156. Nakamura, Y. (2002). Regulating factors for microglial activation. Biol. Pharm. Bull. 25, 945-953. doi: 10.1248/bpb.25.945
157. Neumann, H., Kotter, M. R., and Franklin, R. J. (2009). Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 132, 288-295. doi: 10.1093/brain/awn109
158. Ng, Y. K., Yong, V. W., and Ling, E. A. (1999). Microglial reaction in some CNS nuclei following nerves transection in BALB/c and interferon-gamma gene knockout mice. Neurosci. Lett. 262, 207-210.doi: 10.1016/s0304-3940(99)00076-2
159. Nguyen, M. D., Julien, J. P., and Rivest, S. (2002). Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat. Rev. Neurosci. 3, 216-227. doi: 10.1038/nrn752
160. Nikolic, D., Calderon, L., Du, L., and Post, S. R. (2011). SR-A ligand M-CSF dynamically regulate SR-A expression and function in primary macrophages via p38 MAPK activation. BMC Immunol. 12:37. doi: 10.1186/1471-2172-12-37
161. Nishimura, N., Harada-Shiba, M., Tajima, S., Sugano, R., Yamamura, T., Qiang, Q. Z., et al. (1998). Acquisition of secretion of transforming growth factor-beta 1 leads to autonomous suppression of scavenger receptor activity in a monocyte-macrophage cell line, THP-1. J. Biol. Chem. 273, 1562-1567. doi: 10.1074/jbc.273.3.1562
162. O’Neill, L. A., and Kaltschmidt, C. (1997). NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20, 252-258. doi: 10.1016/s0166-2236(96)01035-1
163. Ong, C. T., and Corces, V. G. (2014). CTCF: an architectural protein bridging genome topology and function. Nat. Rev. Genet. 15, 234-246. doi: 10.1038/nrg3663
164. Pannaccione, A., Secondo, A., Scorziello, A., Cali, G., Taglialatela, M., and Annunziato, L. (2005). Nuclear factor-kappaB activation by reactive oxygen species mediates voltage-gated K+ current enhancement by neurotoxic beta-amyloid peptides in nerve growth factor-differentiated PC-12 cells and hippocampal neurones. J. Neurochem. 94, 572-586. doi: 10.1111/j.1471-4159.2005.03075.x
165. Paresce, D. M., Chung, H., and Maxfield, F. R. (1997). Slow degradation of aggregates of the Alzheimer’s disease amyloid beta-protein by microglial cells. J. Biol. Chem. 272,29390-29397. doi: 10.1074/jbc.272.46.29390
166. Paresce, D.M., Ghosh, R. N., andMaxfield,F. R. (1996). Microglial cells internalize aggregates of the Alzheimer’s disease amyloid beta-protein via a scavenger receptor. Neuron 17, 553-565. doi: 10.1016/s0896-6273(00)80187-7
167. Paris, D., Patel, N., Quadros, A., Linan, M., Bakshi, P., Ait-Ghezala, G., et al. Inhibition of Abeta production by NF-kappaB inhibitors. Neurosci. Lett. 415, 11-16. doi: 10.1016/j.neulet.2006.12.029
168. Pawate, S., Shen, Q., Fan, F., and Bhat, N. R. (2004). Redox regulation of glial inflammatory response to lipopolysaccharide and interferongamma. J. Neurosci. Res. 77, 540-551. doi: 10.1002/jnr.20180
169. Pei, J. J., Braak, E., Braak, H., Grundke-Iqbal, I., Iqbal, K., Winblad, B., et al. (2001). Localization of active forms of C-jun kinase (JNK) and p38 kinase in Alzheimer’s disease brains at different stages of neurofibrillary degeneration. J. Alzheimers. Dis. 3, 41-48.
170. Pineda, J. R., Daynac, M., Chicheportiche, A., Cebrian-Silla, A., Sii Felice, K., Garcia-Verdugo, J. M., et al. (2013). Vascular-derived TGF-beta increases in the stem cell niche and perturbs neurogenesis during aging and following irradiation in the adult mouse brain. EMBO Mol. Med. 5, 548-562. doi: 10.1002/emmm.201202197
171. Platanias, L. C. (2005). Mechanisms of type-I-and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5, 375-386. doi: 10.1038/nri1604
172. Porta, C., Rimoldi, M., Raes, G., Brys, L., Ghezzi, P., Di Liberto, D., et al. (2009). Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc. Natl. Acad. Sci. USA 106, 14978-14983. doi: 10.1073/pnas.0809784106
173. Prehn, J. H., Bindokas, V. P., Jordan, J., Galindo, M. F., Ghadge, G. D., Roos, R. P., et al. (1996). Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons. Mol. Pharmacol. 49, 319-328.
174. Qian, J. J., Cheng, Y. B., Yang, Y. P., Mao, C. J., Qin, Z. H., Li, K., et al. Differential effects of overexpression of wild-type and mutant human a-synuclein on MPP+-induced neurotoxicity in PC12 cells. Neurosci Lett. 435, 142-146. doi: 10.1016/j.neulet.2008.02.021
175. Qin, H., Chan, M. W., Liyanarachchi, S., Balch, C., Potter, D., Souriraj, I. J., et al. (2009). An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules. BMC Syst. Biol. 3:73. doi: 10.1186/17520509-3-73
176. Qin, L., Li, G., Qian, X., Liu, Y., Wu, X., Liu, B., et al. (2005). Interactive role of the toll-like receptor 4 and reactive oxygen species in LPS-induced microglia activation. Glia 52, 78-84. doi: 10.1002/glia.20225
177. Rahimi, R. A., and Leof, E. B. (2007). TGF-beta signaling: a tale of two responses. J. Cell. Biochem. 102, 593-608. doi: 10.1002/jcb.21501
178. Raj, D. D., Jaarsma, D., Holtman, I. R., Olah, M., Ferreira, F. M., Schaafsma, W., et al. (2014). Priming of microglia in a DNA-repair deficient model of accelerated aging. Neurobiol. Aging 35, 2147-2160. doi: 10.1016/j.neurobiolaging.2014.03.025
179. Ramirez, G., Rey, S., and Von Bernhardi, R. (2008). Proinflammatory stimuli are needed for induction of microglial cell-mediated AbetaPP_244-C and Abeta-neurotoxicity in hippocampal cultures. J. Alzheimers. Dis. 15, 45-59.
180. Ramirez, G., Toro, R., Dobeli, H., and Von Bernhardi, R. (2005). Protection of rat primary hippocampal cultures from A beta cytotoxicity by pro-inflammatory molecules is mediated by astrocytes. Neurobiol. Dis. 19,243-254. doi: 10.1016/j.nbd.2005.01.007
181. Ransohoff, R. M., and Perry, V. H. (2009). Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 27,119-145. doi: 10.1146/annurev.immunol.021908.132528
182. Rivest, S. (2009). Regulation of innate immune responses in the brain. Nat. Rev. Immunol. 9,429-439. doi: 10.1038/nri2565
183. Rogers, J., Strohmeyer, R., Kovelowski, C. J., and Li, R. (2002). Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia 40, 260-269. doi: 10.1002/glia.10153
184. Rosales-Corral, S., Reiter, R. J., Tan, D. X., Ortiz, G. G., and Lopez-Armas, G. (2010). Functional aspects of redox control during neuroinflammation. Antioxid. Redox Signal. 13, 193-247. doi: 10.1089/ars.2009.2629
185. Ross, K. R., Corey, D. A., Dunn, J. M., and Kelley, T. J. (2007). SMAD3 expression is regulated by mitogen-activated protein kinase kinase-1 in epithelial and smooth muscle cells. Cell. Signal. 19, 923-931. doi: 10.1016/j.cellsig.2006.11.008
186. Ross, S., and Hill, C. S. (2008). How the Smads regulate transcription. Int. J. Biochem. Cell Biol. 40, 383-408. doi: 10.1016/j.biocel.2007.09.006
187. Rossner, S., Lange-Dohna, C., Zeitschel, U., and Perez-Polo, J. R. (2005). Alzheimer’s disease beta-secretase BACE1 is not a neuron-specific enzyme. J. Neurochem. 92, 226-234. doi: 10.1111/j.1471-4159.2004.02857.x
188. Saha, R. N., Jana, M., and Pahan, K. (2007). MAPK p38 regulates transcriptional activity of NF-kappaB in primary human astrocytes via acetylation of p65. J. Immunol. 179, 7101-7109. doi: 10.4049/jimmunol.179.10.7101
189. Satoh, T., and Lipton, S. A. (2007). Redoxregulationofneuronal survival mediated by electrophilic compounds. Trends Neurosci. 30, 37-45. doi: 10.1016/j.tins.2006.11.004
190. Satoh, T., Takeuchi, O., Vandenbon, A., Yasuda, K., Tanaka, Y., Kumagai, Y., et al. (2010). The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol. 11, 936-944. doi: 10.1038/ni.1920
191. Saud, K., Herrera-Molina, R., and Von Bernhardi, R. (2005). Pro-and anti-inflammatory cytokines regulate the ERK pathway: implication of the timing for the activation of microglial cells. Neurotox. Res. 8, 277-287. doi: 10.1007/bf03033981
192. Schmierer, B., and Hill, C. S. (2007). TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat. Rev. Mol. Cell Biol. 8, 970-982. doi: 10.1038/nrm2297
193. Schwab, C., and McGeer, P. L. (2008). Inflammatory aspects ofAlzheimer disease and other neurodegenerative disorders. J. Alzheimers Dis. 13, 359-369.
194. Selkoe, D. J. (2002). Alzheimer’s disease is a synaptic failure. Science 298, 789-791. doi: 10.1126/science.1074069
195. Siegenthaler, J. A., and Miller, M. W. (2004). Transforming growth factor beta1 modulates cell migration in rat cortex: effects of ethanol. Cereb. Cortex 14, 791-802. doi: 10.1093/cercor/bhh039
196. Sierra, A., Gottfried-Blackmore, A. C., McEwen, B. S., and Bulloch, K. (2007). Microglia derived from aging mice exhibit an altered inflammatory profile. Glia 55, 412-424. doi: 10.1002/glia.20468
197. Simonsson, M., Kanduri, M., Gronroos, E., Heldin, C. H., and Ericsson, J. (2006). The DNA binding activities of Smad2 and Smad3 are regulated by coactivator-mediated acetylation. J. Biol. Chem. 281, 39870-39880. doi: 10.1074/jbc.m607868200
198. Singh, T., and Newman, A. B. (2011). Inflammatory markers in population studies of aging. Ageing Res. Rev. 10, 319-329. doi: 10.1016/j.arr.2010.11.002
199. Spriggs, D. R., Deutsch, S., and Kufe, D. W. (1992). Genomic structure, induction and production of TNF-alpha. Immunol. Ser. 56, 3-34.
200. Streit, W. J. (2002). Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40, 133-139. doi: 10.1002/glia.10154
201. Sun, A., Liu, M., Nguyen, X. V., and Bing, G. (2003). P38 MAP kinase is activated at early stages in Alzheimer’s disease brain. Exp. Neurol. 183, 394-405. doi: 10.1016/s0014-4886(03)00180-8
202. Tapia-Gonzalez, S., Munoz, M. D., Cuartero,M. I., and Sanchez-Capelo, A. (2013). Smad3 is required for the survival of proliferative intermediate progenitor cells in the dentate gyrus of adult mice. Cell Commun. Signal. 11:93. doi: 10.1186/1478-811x-11-93
203. Tarkowski, E., Issa, R., Sjogren, M., Wallin, A., Blennow, K., Tarkowski, A., et al. (2002). Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer’s disease and vascular dementia. Neurobiol. Aging 23, 237-243. doi: 10.1016/s0197-4580(01)00285-8
204. Taylor, R. C., and Dillin, A. (2011). Aging as an event of proteostasis collapse. ColdSpringHarb. Perspect. Biol. 3:a004440. doi: 10.1101/cshperspect.a004440
205. Tesseur, I., and Wyss-Coray, T. (2006). A role for TGF-beta signaling in neurodegeneration: evidence from genetically engineered models. Curr. Alzheimer Res. 3, 505-513. doi: 10.2174/156720506779025297
206. Tesseur, I., Zou, K., Esposito, L., Bard, F., Berber, E., Can, J. V., et al. (2006). Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer’s pathology. J. Clin. Invest. 116, 3060-3069. doi: 10.1172/jci27341
207. Tichauer, J., Saud, K., and von Bernhardi, R. (2007). Modulation by astrocytes of microglial cell-mediated neuroinflammation: effect on the activation of microglial signaling pathways. Neuroimmunomodulation 14, 168-174. doi: 10.1159/000110642
208. Tichauer, J. E., and von Bernhardi, R. (2012). Transforming growth factor-beta stimulates beta amyloid uptake by microglia through Smad3-dependent mechanisms. J. Neurosci. Res. 90, 1970-1980. doi: 10.1002/jnr.23082
209. Tichauer, J. E., Flores, B., Soler, B., Eugenin-von Bernhardi, L., Ramirez, G., and von Bernhardi, R. (2014). Age-dependent changes on TGFbeta1 Smad3 pathway modify the pattern of microglial cell activation. Brain Behav. Immun. 37, 187-196. doi: 10.1016/j.bbi.2013.12.018
210. Tong, X. K., and Hamel, E. (2007). Transforming growth factor-beta 1 impairs endothelin-1-mediated contraction of brain vessels by inducing mitogen-activated protein (MAP) kinase phosphatase-1 and inhibiting p38 MAP kinase. Mol. Pharmacol. 72, 1476-1483. doi: 10.1124/mol.107.039602
211. Town, T., Laouar, Y., Pittenger, C., Mori, T., Szekely, C. A., Tan, J., et al. (2008). Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nat. Med. 14, 681-687. doi: 10.1038/nm1781
212. Town, T., Nikolic, V., and Tan, J. (2005). The microglial ‘‘activation’’ continuum: from innate to adaptive responses. J. Neuroinflammation 2:24. doi: 10.1186/1742-2094-2-24
213. Tran, M. H., Yamada, K., Olariu, A., Mizuno, M., Ren, X. H., and Nabeshima, T. (2001). Amyloid beta-peptide induces nitric oxide production in rat hippocampus: association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors. FASEB . 15, 1407-1409. doi: 10.1096/fj.00-0719fje
214. Tu, A. W., and Luo, K. (2007). Acetylation of Smad2 by the co-activator p300 regulates activin and transforming growth factor beta response. J. Biol. Chem. 282,21187-21196. doi: 10.1074/jbc.m700085200
215. Ueberham, U., Lange, P., Ueberham, E., Bruckner, M. K., Hartlage-Rubsamen, M., Pannicke, T., et al. (2009). Smad2 isoforms are differentially expressed during mouse brain development and aging. Int. J. Dev. Neurosci. 27, 501-510.doi: 10.1016/j.ijdevneu.2009.04.001
216. Ueberham, U., Ueberham, E., Gruschka, H., and Arendt, T. (2006). Altered subcellular location of phosphorylated Smads in Alzheimer’s disease. Eur. J. Neurosci. 24,2327-2334. doi: 10.1111/j.1460-9568.2006.05109.x
217. Ulloa, L., Doody, J., and Massague, J. (1999). Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature 397,710-713. doi: 10.1038/17826
218. Uribe-San Marten, R., Herrera-Molina, R., Olavarrea, L., Ramerez, G., and von Bernhardi, R. (2009). Reduction of beta-amyloid-induced neurotoxicity on hippocampal cell cultures by moderate acidosis is mediated by transforming growth factor beta. Neuroscience 158, 1338-1347. doi: 10.1016/j.neuroscience.2008.11.002
219. Uylings, H. B., and de Brabander, J. M. (2002). Neuronal changes in normal human aging and Alzheimer’s disease. Brain Cogn. 49, 268-276. doi: 10.1006/brcg.2001.1500
220. Valerio, A., Boroni, F., Benarese, M., Sarnico, I., Ghisi, V., Bresciani, L. G., et al. (2006). NF-kappaB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production. Eur. J. Neurosci. 23, 1711-1720. doi: 10.1111/j.1460-9568.2006.04722.x
221. Van Eldik, L. J., Thompson, W. L., Ralay Ranaivo, H., Behanna, H. A., and Martin Watterson, D. (2007). Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approaches. Int. Rev. Neurobiol. 82, 277-296. doi: 10.1016/s0074-7742(07)82015-0
222. Venema, R. C., Venema, V. J., Eaton, D. C., and Marrero, M. B. (1998). Angiotensin II-induced tyrosine phosphorylation of signal transducers and activators of transcription 1 is regulated by Janus-activated kinase 2 and Fyn kinases and mitogen-activated protein kinase phosphatase 1. J. Biol. Chem. 273, 30795-30800. doi: 10.1074/jbc.273.46.30795
223. von Bernhardi, R. (2007). Glial cell dysregulation: a new perspective on Alzheimer disease. Neurotox. Res. 12,215-232. doi: 10.1007/bf03033906
224. von Bernhardi, R. (2010). Immunotherapy in Alzheimer’s disease: where do we stand? Where should we go? J. Alzheimers Dis. 19, 405-421. doi: 10.3233/JAD-2010-1248
225. von Bernhardi, R., and Eugenin, J. (2004). Microglial reactivity to beta-amyloid is modulated by astrocytes and proinflammatory factors. Brain Res. 1025, 186-193. doi: 10.1016/j.brainres.2004.07.084
226. von Bernhardi, R., and Ramirez, G. (2001). Microglia-astrocyte interaction in Alzheimer’s disease: friends or foes for the nervous system? Biol. Res. 34, 123-128. doi: 10.4067/s0716-97602001000200017
227. von Bernhardi, R., Eugenin-von Bernhardi, L., and Eugenin, J. (2015). Microglial cell dysregulation in brain aging and neurodegeneration. Front. AgingNeurosci. 7:124. doi: 10.3389/fnagi.2015.00124
228. von Bernhardi, R., Ramirez, G., Toro, R., and Eugenin, J. (2007). Pro-inflammatory conditions promote neuronal damage mediated byAmyloid Precursor Protein and decrease its phagocytosis and degradation by microglial cells in culture. Neurobiol. Dis. 26, 153-164. doi: 10.1016/j.nbd.2006.12.006
229. von Bernhardi, R., Tichauer, J., and Eugenin-von Bernhardi, L. (2011). Proliferating culture of aged microglia for the study of neurodegenerative diseases. J. Neurosci. Methods 202, 65-69. doi: 10.1016/j.jneumeth.2011.08.027
230. von Bernhardi, R., Tichauer, J. E., and Eugenin, J. (2010). Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders. J. Neurochem. 112, 1099-1114. doi: 10.1111/j.1471-4159.2009.06537.x
231. Wang, Q., Wu, J., Rowan, M. J., and Anwyl, R. (2005). Beta-amyloid inhibition of long-term potentiation is mediated via tumor necrosis factor. Eur. J. Neurosci. 22,2827-2832. doi: 10.1111/j.1460-9568.2005.04457.x
232. Wang, Q., Zhang, J. Y., Liu, S. J., and Li, H. L. (2008a). Overactivated mitogen-activated protein kinase by anisomycin induces tau hyperphosphorylation. Sheng Li Xue Bao 60, 485-491.
233. Wang, S. C., Oelze, B., and Schumacher, A. (2008b). Age-specific epigenetic drift in late-onset Alzheimer’s disease. PLoS One 3:e2698. doi: 10.1371/journal.pone.0002698
234. Wang, T., Qin, L., Liu, B., Liu, Y., Wilson, B., Eling, T. E., et al. (2004). Role of reactive oxygen species in LPS-induced production of prostaglandin E2 in microglia. J. Neurochem. 88, 939-947. doi: 10.1046/j.1471-4159.2003.02242.x
235. Weiss, A., and Attisano, L. (2013). The TGFbeta superfamily signaling pathway. WileyInterdiscip. Rev. Dev. Biol. 2,47-63. doi: 10.1002/wdev.86
236. Welser-Alves, J. V., and Milner, R. (2013). Microglia are the major source of TNF-alpha and TGF-beta1 in postnatal glial cultures; regulation by cytokines, lipopolysaccharide and vitronectin. Neurochem. Int. 63, 47-53. doi: 10.1016/j.neuint.2013.04.007
237. Wen, Z., Zhong, Z., and Darnell, J. E., Jr. (1995). Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82, 241-250. doi: 10.1016/0092-8674(95)90311-9
238. Werner, F., Jain, M. K., Feinberg, M. W., Sibinga, N. E., Pellacani, A., Wiesel, P., et al. (2000). Transforming growth factor-beta 1 inhibition of macrophage activation is mediated via Smad3. J. Biol. Chem. 275, 36653-36658. doi: 10.1074/jbc.m004536200
239. Werry, E. L., Enjeti, S., Halliday, G. M., Sachdev, P. S., and Double, K. L. (2010). Effect of age on proliferation-regulating factors in human adult neurogenic regions. J. Neurochem. 115, 956-964. doi: 10.1111/j.1471-4159.2010.06992.x
240. Wrighton, K. H., Lin, X., and Feng, X. H. (2009). Phospho-control of TGF-beta superfamily signaling. Cell Res. 19, 8-20. doi: 10.1038/cr.2008.327
241. Wu, Z., Tokuda, Y., Zhang, X. W., and Nakanishi, H. (2008). Age-dependent responses of glial cells and leptomeninges during systemic inflammation. Neurobiol. Dis. 32, 543-551. doi: 10.1016/j.nbd.2008.09.002
242. Wynne, A. M., Henry, C. J., Huang, Y., Cleland, A., and Godbout, J. P. (2010). Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge. Brain Behav. Immun. 24, 1190-1201. doi: 10.1016/j.bbi.2010.05.011
243. Wyss-Coray, T., and Mucke, L. (2002). Inflammation in neurodegenerative disease-a double-edged sword. Neuron 35, 419-432. doi: 10.1016/s0896-6273(02)00794-8
244. Wyss-Coray, T., Lin, C., Sanan, D. A., Mucke, L., and Masliah, E. (2000). Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer’s disease-like microvascular degeneration in transgenic mice. Am. J. Pathol. 156, 139-150. doi: 10.1016/s0002-9440(10)64713-x
245. Wyss-Coray, T., Lin, C., Yan, F., Yu, G. Q., Rohde, M., McConlogue, L., et al. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat. Med. 7, 612-618. doi: 10.1038/87945
246. Wyss-Coray, T., Masliah, E., Mallory, M., McConlogue, L., Johnson-Wood, K., Lin, C., et al. (1997). Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer’s disease. Nature 389, 603-606. doi: 10.1038/39321
247. Yamamoto, K., Shimokawa, T., Yi, H., Isobe, K., Kojima, T., Loskutoff, D. J., et al. Aging accelerates endotoxin-induced thrombosis: increased responses of plasminogen activator inhibitor-1 and lipopolysaccharide signaling with aging. Am. J. Pathol. 161, 1805-1814. doi: 10.1016/S0002-9440(10)64457-4
248. Yan, J., Zhang, H., Yin, Y., Li, J., Tang, Y., Purkayastha, S., et al. (2014). Obesity-and aging-induced excess of central transforming growth factor-beta potentiates diabetic development via an RNA stress response. Nat. Med. 20, 1001-1008. doi: 10.1038/nm.3616
249. Yang, C. N., Shiao, Y. J., Shie, F. S., Guo, B. S., Chen, P. H., Cho, C. Y., et al. (2011). Mechanism mediating oligomeric Abeta clearance by naive primary microglia. Neurobiol. Dis. 42,221-230. doi: 10.1016/j.nbd.2011.01.005
250. Ye, S. M., and Johnson, R. W. (1999). Increased interleukin-6 expression by microglia from brain of aged mice. J. Neuroimmunol. 93, 139-148. doi: 10.1016/s0165-5728(98)00217-3
251. Zhou, X., Lowdon, R. F., Li, D., Lawson, H. A., Madden, P. A., Costello, J. F., et al. (2013). Exploring long-range genome interactions using the WashU Epigenome Browser. Nat. Methods 10, 375-376. doi: 10.1038/nmeth.2440
252. Zhu, X., Mei, M., Lee, H. G., Wang, Y., Han, J., Perry, G., et al. (2005). P38 activation mediates amyloid-beta cytotoxicity. Neurochem. Res. 30, 791-796. doi: 10.1007/s11064-005-6872-x
253. Zhu, Y., Culmsee, C., Klumpp, S., and Krieglstein, J. (2004). Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways. Neuroscience 123, 897-906. doi: 10.1016/j.neuroscience.2003.10.037
254. Zhu, Y., Yang, G. Y., Ahlemeyer, B., Pang, L., Che, X. M., Culmsee, C., et al. (2002). Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. J. Neurosci. 22, 3898-3909.